Lovenox and Votrient drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lovenox (enoxaparin sodium) and Votrient (pazopanib hydrochloride). Common drug interactions include dyspepsia among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Lovenox and Votrient. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.

What is Votrient?

Votrient has active ingredients of pazopanib hydrochloride. It is often used in metastatic renal cell carcinoma. eHealthMe is studying from 25,347 Votrient users. Check the latest studies of Votrient.

On Jul, 13, 2026

65 people who take Lovenox and Votrient together, and have interactions are studied.

What are the common drug interactions of Lovenox and Votrient, by gender? *:

female:

Dyspepsia (indigestion)
Dyspnoea (difficult or laboured respiration)
Eosinophil count decreased
Fatigue (feeling of tiredness)
Frequent bowel movements
Gingival pain (gum pain)
Haemorrhage (bleeding)
Mean cell haemoglobin concentration decreased (less concentration of haemoglobin in a given volume of packed red blood cells)
Nausea (feeling of having an urge to vomit)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

male:

Nausea (feeling of having an urge to vomit)
Vomiting
Death
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Hilar lymphadenopathy (disease of the lymph nodes due to infection)
Laryngeal oedema (swelling of larynx)
Laryngitis (inflammation of the larynx)
Lip ulceration (ulcer of lip)
Malignant neoplasm progression (cancer tumour came back)

What are the common drug interactions of Lovenox and Votrient, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cardiac arrest
Drug ineffective
Epistaxis (bleed from the nose)
Hip arthroplasty

40-49:

Death
Blood pressure increased
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Chest pain
Cough
Pleural effusion (water on the lungs)
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Thrombosis (formation of a blood clot inside a blood vessel)

50-59:

Abdominal pain
C-reactive protein increased
Fatigue (feeling of tiredness)
Haematemesis (vomiting of blood)
Haematuria (presence of blood in urine)
International normalised ratio increased
Intervertebral disc degeneration (spinal disc degeneration)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Stridor
Therapeutic response decreased (less preventive response)

60+:

Nausea (feeling of having an urge to vomit)
Death
Blood pressure diastolic decreased
Dehydration (dryness resulting from the removal of water)
Drug ineffective
Dyspepsia (indigestion)
Eosinophil count decreased
Frequent bowel movements
Gingival pain (gum pain)
Haemorrhage (bleeding)

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 26 people, 40.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 6.15%
Neoplasm Malignant (cancer tumour): 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Lovenox and Votrient?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously